Syndax Pharmaceuticals, Inc. (SNDX) Operating cash flow 2016–2025
Syndax Pharmaceuticals, Inc. (SNDX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$323.0MFY2025 · since FY2016: -$35.2M → -$323.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$323.0M | -17.5% |
| FY2024 | -$274.9M | -71.2% |
| FY2023 | -$160.6M | -20.1% |
| FY2022 | -$133.7M | -558.9% |
| FY2021 | $29.1M | +140.9% |
| FY2020 | -$71.3M | -40.8% |
| FY2019 | -$50.6M | +26.1% |
| FY2018 | -$68.5M | -44.7% |
| FY2017 | -$47.4M | -34.7% |
| FY2016 | -$35.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice